Libura, M., Bialopiotrowicz, E., Giebel, S., Wierzbowska, A., Roboz, G. J., Piatkowska-Jakubas, B., . . . Haus, O. (2021). IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen. Nature Portfolio.
Style de citation Chicago (17e éd.)Libura, Marta, et al. IDH2 Mutations in Patients with Normal Karyotype AML Predict Favorable Responses to Daunorubicin, Cytarabine and Cladribine Regimen. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Libura, Marta, et al. IDH2 Mutations in Patients with Normal Karyotype AML Predict Favorable Responses to Daunorubicin, Cytarabine and Cladribine Regimen. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.